UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Cannbinoids and ImmunityPromising Pre-Clinical Findings Open the Door to Significant Clinical Applications

European journal of rheumatology, 2024-05, Vol.11 (S2), p.S172

2024

Volltextzugriff (PDF)

A randomized controlled trial of visible-light therapy for the prevention of oral mucositis

Oral oncology, 2011-02, Vol.47 (2), p.125-130

2011

Volltextzugriff (PDF)

Immunotherapeutic approaches to improve graft-versus-tumor effect and reduce graft-versus-host disease

Immunotherapy, 2012-04, Vol.4 (4), p.407-424

2012

Volltextzugriff (PDF)

A New Cellular Immunotherapy for the Treatment of Multiple Myeloma without Development of Graft-Versus-Host Disease

Blood, 2018-11, Vol.132 (Supplement 1), p.3339-3339

2018

Volltextzugriff (PDF)

Second bone marrow transplantation for patients with thalassemia: risks and benefits

Haematologica (Roma), 2009-09, Vol.94 (9), p.1329-1330

2009

Volltextzugriff (PDF)

Low-intensity conditioning is sufficient to ensure engraftment in matched unrelated bone marrow transplantation

Experimental hematology, 2001-03, Vol.29 (3), p.362-370

2001

Volltextzugriff (PDF)

Prognostic value of blood biomarkers in steroid-refractory or steroid-dependent acute graft-versus-host disease: a REACH2 analysis

Blood, 2023-06, Vol.141 (22), p.2771-2779

2023

Volltextzugriff (PDF)

Prognostic Value of Blood Biomarkers in Steroid-Refractory/Dependent Acute Graft-vs-Host Disease: A REACH2 Analysis

Blood, 2023-02

2023

Volltextzugriff (PDF)

Adoptive transfer of pp65-specific T cells for the treatment of chemorefractory cytomegalovirus disease or reactivation after haploidentical and matched unrelated stem cell transplantation

Blood, 2010-11, Vol.116 (20), p.4360-4367

2010

Volltextzugriff (PDF)

Single Infusion of Donor Mononuclear Early Apoptotic Cells as Prophylaxis for Graft-versus-Host Disease in Myeloablative HLA-Matched Allogeneic Bone Marrow Transplantation: A Phase I/IIa Clinical Trial

Biology of blood and marrow transplantation, 2014, Vol.20 (1), p.58-65

2014

Volltextzugriff (PDF)

A randomized study comparing yttrium‐90 ibritumomab tiuxetan (Zevalin) and high‐dose BEAM chemotherapy versus BEAM alone as the conditioning regimen before autologous stem cell transplantation in patients with aggressive lymphoma

Cancer, 2012-10, Vol.118 (19), p.4706-4714

2012

Volltextzugriff (PDF)

A non-myeloablative conditioning regimen in allogeneic stem cell transplantation from related and unrelated donors in elderly patients

Haematologica (Roma), 2006-06, Vol.91 (6), p.852-855

2006

Volltextzugriff (PDF)

Phase I/II study exploring ImMucin, a pan‐major histocompatibility complex, anti‐MUC1 signal peptide vaccine, in multiple myeloma patients

British journal of haematology, 2015-04, Vol.169 (1), p.44-56

2015

Volltextzugriff (PDF)

Simultaneous Donor Marrow Cell Transplantation With Reduced Intensity Conditioning Prevents Tracheal Allograft Obliteration in a Bronchiolitis Obliterans Murine Model

Chest, 2005-12, Vol.128 (6), p.4024-4029

2005

Volltextzugriff (PDF)

Results and factors influencing outcome after fully haploidentical hematopoietic stem cell transplantation in children with very high-risk acute lymphoblastic leukemia: impact of center size: an analysis on behalf of the Acute Leukemia and Pediatric Disease Working Parties of the European Blood and Marrow Transplant group

Blood, 2010-04, Vol.115 (17), p.3437-3446

2010

Volltextzugriff (PDF)

Outcome of haematopoietic stem cell transplantation in dyskeratosis congenita

British journal of haematology, 2018-10, Vol.183 (1), p.110-118

2018

Volltextzugriff (PDF)

Augmented myeloablative conditioning with thiotepa in acute myeloid leukemia - improved outcomes with similar toxicity

Leukemia & lymphoma, 2019-02, Vol.60 (3), p.726-733

2019

Volltextzugriff (PDF)

Time limitations and the challenge of providing infection-preventing dental care to hematopoietic stem-cell transplantation patients

Supportive care in cancer, 2003-10, Vol.11 (10), p.674-677

2003

Volltextzugriff (PDF)

Single-Infusion of Donor Early Apoptotic Cells (ApoCell) As Prophylaxis of Graft-Versus-Host Disease in Myeloablative HLA-Matched Allogeneic Bone Marrow Transplantati

Blood, 2012-11, Vol.120 (21), p.4176-4176

2012

Volltextzugriff (PDF)

Thiotepa-based conditioning versus total body irradiation as myeloablative conditioning prior to allogeneic stem cell transplantation for acute lymphoblastic leukemia: A matched-pair analysis from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation

American journal of hematology, 2017-10, Vol.92 (10), p.997-1003

2017

Volltextzugriff (PDF)

Improved Outcomes of Hematopoietic Stem Cell Transplantation in Patients With Infantile Malignant Osteopetrosis Using Fludarabine-Based Conditioning

Pediatric blood & cancer, 2016-03, Vol.63 (3), p.535-540

2016

Volltextzugriff (PDF)

Differential Effects of D9 Tetrahydrocannabinol -Based Cannabinoid Treatments on Macrophage Immune Function In Vitro and on Gastrointestinal Inflammation in a Murine Model

Biomedicines, 2022-07, Vol.10 (8)

2022

Volltextzugriff (PDF)

Fludarabine‐based reduced toxicity yet myeloablative conditioning is effective and safe particularly in patients with high‐risk thalassemia undergoing allogeneic transplantation

Pediatric blood & cancer, 2018-11, Vol.65 (11), p.e27312-n/a

2018

Volltextzugriff (PDF)

Plasmacytoma of the testis in a patient with previous multiple myeloma: is the testis a sanctuary site?

Journal of clinical oncology, 2010-09, Vol.28 (27), p.e456-e458

2010

Volltextzugriff (PDF)

26 – 50 von 8.920

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(6.194)
Mit Volltextzugriff
(7.211)

Publikationsform

8 weitere anzeigen...

Weniger anzeigen...

Sprache

8 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(34)
... seit 30 Tagen
(14)

Menü

Weitere Dienste

Einstellungen

Cannbinoids and ImmunityPromising Pre-Clinical Findings Open the Door to Significant Clinical Applications

A randomized controlled trial of visible-light therapy for the prevention of oral mucositis

Immunotherapeutic approaches to improve graft-versus-tumor effect and reduce graft-versus-host disease

A New Cellular Immunotherapy for the Treatment of Multiple Myeloma without Development of Graft-Versus-Host Disease

Second bone marrow transplantation for patients with thalassemia: risks and benefits

Low-intensity conditioning is sufficient to ensure engraftment in matched unrelated bone marrow transplantation

Prognostic value of blood biomarkers in steroid-refractory or steroid-dependent acute graft-versus-host disease: a REACH2 analysis

Prognostic Value of Blood Biomarkers in Steroid-Refractory/Dependent Acute Graft-vs-Host Disease: A REACH2 Analysis

Adoptive transfer of pp65-specific T cells for the treatment of chemorefractory cytomegalovirus disease or reactivation after haploidentical and matched unrelated stem cell transplantation

Single Infusion of Donor Mononuclear Early Apoptotic Cells as Prophylaxis for Graft-versus-Host Disease in Myeloablative HLA-Matched Allogeneic Bone Marrow Transplantation: A Phase I/IIa Clinical Trial

A randomized study comparing yttrium‐90 ibritumomab tiuxetan (Zevalin) and high‐dose BEAM chemotherapy versus BEAM alone as the conditioning regimen before autologous stem cell transplantation in patients with aggressive lymphoma

A non-myeloablative conditioning regimen in allogeneic stem cell transplantation from related and unrelated donors in elderly patients

Phase I/II study exploring ImMucin, a pan‐major histocompatibility complex, anti‐MUC1 signal peptide vaccine, in multiple myeloma patients

Simultaneous Donor Marrow Cell Transplantation With Reduced Intensity Conditioning Prevents Tracheal Allograft Obliteration in a Bronchiolitis Obliterans Murine Model

Outcome of haematopoietic stem cell transplantation in dyskeratosis congenita

Augmented myeloablative conditioning with thiotepa in acute myeloid leukemia - improved outcomes with similar toxicity

Time limitations and the challenge of providing infection-preventing dental care to hematopoietic stem-cell transplantation patients

Single-Infusion of Donor Early Apoptotic Cells (ApoCell) As Prophylaxis of Graft-Versus-Host Disease in Myeloablative HLA-Matched Allogeneic Bone Marrow Transplantati

Thiotepa-based conditioning versus total body irradiation as myeloablative conditioning prior to allogeneic stem cell transplantation for acute lymphoblastic leukemia: A matched-pair analysis from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation

Improved Outcomes of Hematopoietic Stem Cell Transplantation in Patients With Infantile Malignant Osteopetrosis Using Fludarabine-Based Conditioning

Differential Effects of D9 Tetrahydrocannabinol -Based Cannabinoid Treatments on Macrophage Immune Function In Vitro and on Gastrointestinal Inflammation in a Murine Model

Fludarabine‐based reduced toxicity yet myeloablative conditioning is effective and safe particularly in patients with high‐risk thalassemia undergoing allogeneic transplantation

Plasmacytoma of the testis in a patient with previous multiple myeloma: is the testis a sanctuary site?

Biomarker Analysis in Patients (pts) with Steroid-Refractory Acute Graft-Vs-Host Disease (aGVHD) Treated with Ruxolitinib (RUX) or Best Available Therapy (BAT) in the Randomized, Phase 3 REACH2 Study

Suchergebnisse filtern